Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|HPLC-Tested Batches|>99% Purity Specification|Same Day Shipping|Batch-Specific COAs|Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|HPLC-Tested Batches|>99% Purity Specification|Same Day Shipping|Batch-Specific COAs|Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|HPLC-Tested Batches|>99% Purity Specification|Same Day Shipping|Batch-Specific COAs|Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|HPLC-Tested Batches|>99% Purity Specification|Same Day Shipping|Batch-Specific COAs|
peptide dosing

Biotinoyl Tripeptide-1 Dosing & Reconstitution Guide

Marcus Hopkin, PhD, Director of Research and Development at Volta Peptides.

Reviewed by Marcus Hopkin, PhD

Director of Research and Development, Volta Peptides

Written by Volta Peptides Editorial Team · Reviewed September 15, 2026

June 17, 2026Updated September 11, 2026

This document serves as a comprehensive resource for researchers working with Biotinoyl Tripeptide-1, a cosmetic peptide often utilized in formulations aimed at promoting hair health. It includes critical information on reconstitution procedures, dosing parameters, pharmacokinetics, and optimal storage conditions, with an emphasis on research applications. The content is designed to support informed decision-making in laboratory settings, emphasizing conservative usage and adherence to safety protocols.

Dosing Protocol

Biotinoyl Tripeptide-1 is typically administered via topical application, specifically targeting the scalp area. Research literature indicates that formulations such as hair serums or lotions often incorporate Biotinoyl Tripeptide-1 within a complex, such as Procapil, to enhance efficacy. The frequency of application is generally once daily, aligning with studies that suggest consistent use may optimize potential benefits. The dose range for topical products containing Biotinoyl Tripeptide-1 varies, reflecting the concentrations utilized in commercial formulations. While specific dosing parameters may differ across studies, it is essential to reference the product specifications and relevant literature to ensure appropriate application in research contexts.

In Stock

BPC-157 5mg

5mg

Batch purity 99.9%· 10mg lot
$35 USD
In Stock

5-Amino-1MQ 10mg

Batch purity 99.7%
$43 USD
In Stock

BPC-157 10mg

10mg

Batch purity 99.9%
$46 USD

Safety & Contraindications

Biotinoyl Tripeptide-1 is generally regarded as safe for topical use, with numerous studies indicating it is well tolerated in hair care products. No significant adverse effects have been reported in the context of its application, which is attributed to the naturally occurring nature of its components, such as biotin and GHK. These compounds are known for their favorable safety profiles, contributing to the overall acceptability of Biotinoyl Tripeptide-1 in cosmetic formulations. However, researchers should be aware of contraindications, particularly the potential for allergic reactions. Individuals with a known allergy to any component of the formulation should avoid use to mitigate the risk of adverse effects. As always, thorough assessment and monitoring are recommended in research settings.

Shop Research Peptides

In Stock

BPC-157 5mg

5mg

Batch purity 99.9%· 10mg lot
$35 USD
In Stock

5-Amino-1MQ 10mg

Batch purity 99.7%
$43 USD
In Stock

BPC-157 10mg

10mg

Batch purity 99.9%
$46 USD
In Stock

Cagrilintide 5mg

$57 USD
In Stock

DSIP 10mg

$46.71 USD
In Stock

Epithalon 10mg

$34 USD
In Stock

GHK-Cu 100mg

Batch purity 99.8%
$59 USD
In Stock

GHK-Cu 50mg

Batch purity 99.8%· 100mg lot
$39 USD
In Stock

GHRP-2 5mg

5mg

$28 USD

Quality Documentation

Review batch documentation before making research purchasing decisions. Volta pairs product education with COA literacy so researchers can evaluate purity, identity, lot details, and testing context.

Product cards on this page link to current catalog entries and available quality documentation.

Frequently Asked Questions

Related Research

About the reviewer

Marcus Hopkin, PhD, Director of Research and Development at Volta Peptides.

Marcus Hopkin, PhD

Director of Research and Development, Volta Peptides

Marcus Hopkin, PhD, is Director of Research and Development at Volta Peptides. He has more than 12 years of analytical chemistry experience, including direct laboratory work in peptide synthesis, characterization, purity testing and stability assessment. His doctoral research at the University of Michigan examined novel peptide structures in the human proteome and their potential significance for therapeutic-peptide research. Before joining Volta Peptides he held research and development roles at Amgen and Eli Lilly and Company, and served as a lecturer at the University of Michigan.

Marcus reviewed this article for scientific and analytical accuracy on September 15, 2026. He did not write it. Technical review is internal review and is not peer review, independent third-party review or medical review.

Disclosure. Marcus Hopkin is an employee of Volta Peptides and serves as its Director of Research and Development. Volta Peptides sells research compounds related to subjects discussed in the content he writes and reviews. His reviews are internal scientific and technical review and must not be described as independent third-party review, peer review or medical review.

Research Use Only. The information on this page is compiled from published research literature and is provided for educational purposes only. It does not constitute medical advice. All compounds referenced are intended for in vitro research use by qualified laboratories and institutions.

Your Cart

Your cart is empty

Browse our catalog to add research compounds.